高级检索
    孙月丽. Atezolizumab联合EP方案在广泛期小细胞肺癌的一线治疗中获批[J]. 循证医学, 2019, 19(2): 65-65. DOI: 10.12019/j.issn.1671-5144.2019.02.001
    引用本文: 孙月丽. Atezolizumab联合EP方案在广泛期小细胞肺癌的一线治疗中获批[J]. 循证医学, 2019, 19(2): 65-65. DOI: 10.12019/j.issn.1671-5144.2019.02.001
    shu
    SUN Yue-li. FDA Approves Atezolizumab in Combination with Chemotherapy for The Initial Treatment of Adults with Extensive-Stage Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(2): 65-65. DOI: 10.12019/j.issn.1671-5144.2019.02.001
    Citation: SUN Yue-li. FDA Approves Atezolizumab in Combination with Chemotherapy for The Initial Treatment of Adults with Extensive-Stage Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(2): 65-65. DOI: 10.12019/j.issn.1671-5144.2019.02.001
    shu

    Atezolizumab联合EP方案在广泛期小细胞肺癌的一线治疗中获批

    FDA Approves Atezolizumab in Combination with Chemotherapy for The Initial Treatment of Adults with Extensive-Stage Small Cell Lung Cancer

      摘要
      • HTML全文
      • 参考文献(4)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回